Insider · CIK 0001883914
Joseph Edward Tucker
Files at ENVB (Enveric Biosciences, Inc.), LABT (Lakewood-Amedex Biotherapeutics Inc.). First filing -, latest -.
In brief
Joseph Edward Tucker files SEC Form 4 as CEO and director at ENVB (Enveric Biosciences, Inc.), and also at LABT (Lakewood-Amedex Biotherapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Joseph Edward Tucker has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | ENVB Enveric Biosciences, Inc. | AGrant or award Common Stock | +201,124 | $0.00 | $0 | 271,479 | Jun 3, 2026 |
| Apr 24, 2026 | LABT Lakewood-Amedex Biotherapeutics Inc. | AGrant or award Warrant to acquire Common Stockderivative | +33,784 | $0.00 | $0 | 33,784 | May 6, 2026 |
| Dec 23, 2025 | ENVB Enveric Biosciences, Inc. | AGrant or award Common Stock | +60,296 | $0.00 | $0 | 70,355 | Dec 30, 2025 |
| May 8, 2025 | ENVB Enveric Biosciences, Inc. | AGrant or award Common Stock | +98,866 | $0.00 | $0 | 120,711 | May 12, 2025 |
| Oct 9, 2024 | ENVB Enveric Biosciences, Inc. | AGrant or award Common Stock | +161,633 | $0.00 | $0 | 335,829 | Oct 11, 2024 |
Questions about Joseph Edward Tucker
Answered from the filings on this page, as of the latest one.
Is Joseph Edward Tucker buying or selling?
Joseph Edward Tucker has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Joseph Edward Tucker's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joseph Edward Tucker has 0.
Where does Joseph Edward Tucker file Form 4?
Joseph Edward Tucker has filed Form 4 at ENVB (Enveric Biosciences, Inc.) as Chief Executive Officer; LABT (Lakewood-Amedex Biotherapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.